Mar 25 |
Altamira stock rallies 44% on Univercells mRNA collaboration
|
Mar 25 |
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
|
Feb 7 |
Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal
|
Jan 24 |
Altamira Therapeutics stock jumps 7% as it files for second patent
|
Jan 24 |
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
|
Jan 8 |
Altamira Therapeutics files to sell 162.5K shares
|
Jan 8 |
Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit
|
Dec 29 |
Altamira Therapeutics stock rises after it regains compliance with Nasdaq
|
Dec 29 |
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
|
Dec 13 |
Altamira Therapeutics Ltd. (CYTO) Special Call Transcript
|